Monthly Archives: January 2015

Important Update: 168 Week Data Released

Dear Friends: This week, Sarepta Therapeutics released 168 week data from its ongoing eteplirsen study.  This new data strongly confirms the safety and efficacy of eteplirsen and once again calls into question the unreasonable delays and barriers to approval raised by the Division of Neurology Products at the FDA. According to a company press release,… Read more »

Eteplirsen Works on Legs and Lungs…If It Gets to them Fast Enough

By Tracy Seckler Sarepta’s 168 Week Data Affirm Safety and Efficacy Early this morning, Sarepta Therapeutics released more data from the company’s long-term clinical trial testing eteplirsen. With the release of this data, I am heartbroken. But not because the results disappoint. I am crushed because this treatment is so promising, so safe, and so… Read more »